Clinical Trial

Ventilation and Perfusion in Asthmatics

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Assess regional changes to perfusion and ventilation from inhaled corticosteroid (ICS) and Fast-acting beta-antagonist (FABA) among adult asthmatics using radiographically derived estimates of regional ventilation (V-distribution), ventilation defect percentage (VDP), and ventilation heterogeneity (VH).
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-06
Trial Details
NCT Number NCT07426458
Lead Sponsor University of Miami
Collaborators: Australian Lung Health Initiative Pty Ltd
Conditions Asthma
Enrollment 40 participants
Start Date 2026-04-27
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-05